Intellia Therapeutics, Inc.
Polynucleotides, Compositions, and Methods for Genome Editing

Last updated:

Abstract:

Compositions and methods for gene editing. In some embodiments, a polynucleotide encoding Cas9 is provided that can provide one or more of improved editing efficiency, reduced immunogenicity, or other benefits.

Status:
Application
Type:

Utility

Filling date:

24 Mar 2020

Issue date:

12 Nov 2020